ATE56207T1 - Dopamin-beta-hydroxylase-inhibitoren. - Google Patents
Dopamin-beta-hydroxylase-inhibitoren.Info
- Publication number
- ATE56207T1 ATE56207T1 AT86300056T AT86300056T ATE56207T1 AT E56207 T1 ATE56207 T1 AT E56207T1 AT 86300056 T AT86300056 T AT 86300056T AT 86300056 T AT86300056 T AT 86300056T AT E56207 T1 ATE56207 T1 AT E56207T1
- Authority
- AT
- Austria
- Prior art keywords
- hydroxylase inhibitors
- alkyl
- dopamine beta
- beta hydroxylase
- hydrogen
- Prior art date
Links
- 108010015720 Dopamine beta-Hydroxylase Proteins 0.000 title 1
- 102100033156 Dopamine beta-hydroxylase Human genes 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical compound O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 abstract 1
- 229910006074 SO2NH2 Inorganic materials 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 239000002220 antihypertensive agent Substances 0.000 abstract 1
- 229940030600 antihypertensive agent Drugs 0.000 abstract 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000003709 fluoroalkyl group Chemical group 0.000 abstract 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- CBOIHMRHGLHBPB-UHFFFAOYSA-N hydroxymethyl Chemical compound O[CH2] CBOIHMRHGLHBPB-UHFFFAOYSA-N 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 125000000565 sulfonamide group Chemical group 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/10—Radicals substituted by halogen atoms or nitro radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/14—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/28—Sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Hospice & Palliative Care (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/689,680 US4728741A (en) | 1985-01-08 | 1985-01-08 | 1-substituted-2-mercapto benzimidazole compounds and intermediates |
| EP86300056A EP0190817B1 (de) | 1985-01-08 | 1986-01-07 | Dopamin-beta-hydroxylase-Inhibitoren |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE56207T1 true ATE56207T1 (de) | 1990-09-15 |
Family
ID=24769487
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT86300056T ATE56207T1 (de) | 1985-01-08 | 1986-01-07 | Dopamin-beta-hydroxylase-inhibitoren. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US4728741A (de) |
| EP (1) | EP0190817B1 (de) |
| JP (1) | JPS61161267A (de) |
| AT (1) | ATE56207T1 (de) |
| AU (2) | AU588562B2 (de) |
| CA (1) | CA1269668A (de) |
| DE (1) | DE3673835D1 (de) |
| DK (1) | DK2886A (de) |
| ES (1) | ES8703844A1 (de) |
| GR (1) | GR860018B (de) |
| PT (1) | PT81786B (de) |
| ZA (1) | ZA8665B (de) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61151176A (ja) * | 1984-12-24 | 1986-07-09 | Sumitomo Chem Co Ltd | ベンズイミダゾール誘導体およびそれを有効成分とする殺虫、殺ダニ剤 |
| JPS63101380A (ja) * | 1986-10-17 | 1988-05-06 | Zeria Shinyaku Kogyo Kk | 新規な２−メルカプトベンズイミダゾ−ル誘導体、それらの製造法およびそれらを有効成分として含有する抗潰瘍剤 |
| IT1226100B (it) * | 1988-07-07 | 1990-12-10 | Dompe Farmaceutici Spa | Derivati benzimidazolici farmacologicamente attivi. |
| GB8904174D0 (en) * | 1989-02-23 | 1989-04-05 | British Bio Technology | Compounds |
| WO1991011999A1 (en) * | 1990-02-13 | 1991-08-22 | Merck & Co., Inc. | Angiotensin ii antagonists incorporating a substituted benzyl element |
| US5106863A (en) * | 1990-03-26 | 1992-04-21 | Ortho Pharmaceutical Corporation | Substituted imidazole and pyridine derivatives |
| EP0474109A1 (de) * | 1990-09-03 | 1992-03-11 | Richter Gedeon Vegyeszeti Gyar R.T. | Neue 5-Benzyl-substituierte Benzimidazolin-2-Thion-Derivate und Verfahren zu ihrer Herstellung |
| GB9101448D0 (en) * | 1991-01-23 | 1991-03-06 | Cox John H | Improved door assembly |
| TW300219B (de) * | 1991-09-14 | 1997-03-11 | Hoechst Ag | |
| US6114532A (en) * | 1998-02-03 | 2000-09-05 | Boehringer Ingelheim Pharma Kg | Bicyclic heterocycles, the preparation thereof, and their use as pharmaceuticals |
| JP2007521296A (ja) * | 2003-07-01 | 2007-08-02 | メルク エンド カムパニー インコーポレーテッド | 高眼圧の治療のための眼科用組成物 |
| DE102007037579B4 (de) * | 2007-08-09 | 2012-05-16 | Emc Microcollections Gmbh | Neue Benzimidazol-2-yl-alkylamine und ihre Anwendung als mikrobizide Wirkstoffe |
| JOP20190049A1 (ar) * | 2016-09-23 | 2019-03-20 | Bial Portela & C? S A | مثبطات دوبامين-b-هيدروكسيلاز |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL302847A (de) * | 1963-01-10 | |||
| DE1542886A1 (de) * | 1966-10-04 | 1970-05-14 | Bayer Ag | Fungizide Mittel |
| BE732508A (de) * | 1968-05-08 | 1969-10-16 | ||
| DE2235093C2 (de) * | 1972-07-18 | 1974-07-04 | Bayer Ag, 5090 Leverkusen | Korrosionsschutzmittel |
| FR2521141A1 (fr) * | 1982-02-09 | 1983-08-12 | Rhone Poulenc Agrochimie | Nouveaux derives du cyano-2 benzimidazole, leur preparation et leur utilisation comme fongicides |
| US4492708A (en) * | 1982-09-27 | 1985-01-08 | Eli Lilly And Company | Antiviral benzimidazoles |
| GB8307865D0 (en) * | 1983-03-22 | 1983-04-27 | Fujisawa Pharmaceutical Co | Benzimidazole derivatives |
| EP0269230A1 (de) * | 1986-10-09 | 1988-06-01 | The Wellcome Foundation Limited | Heterozyklische Verbindungen |
-
1985
- 1985-01-08 US US06/689,680 patent/US4728741A/en not_active Expired - Fee Related
-
1986
- 1986-01-02 AU AU51801/86A patent/AU588562B2/en not_active Ceased
- 1986-01-03 DK DK2886A patent/DK2886A/da not_active Application Discontinuation
- 1986-01-03 PT PT81786A patent/PT81786B/pt not_active IP Right Cessation
- 1986-01-06 ZA ZA8665A patent/ZA8665B/xx unknown
- 1986-01-06 CA CA000499050A patent/CA1269668A/en not_active Expired - Lifetime
- 1986-01-07 GR GR860018A patent/GR860018B/el unknown
- 1986-01-07 ES ES550699A patent/ES8703844A1/es not_active Expired
- 1986-01-07 AT AT86300056T patent/ATE56207T1/de not_active IP Right Cessation
- 1986-01-07 DE DE8686300056T patent/DE3673835D1/de not_active Expired - Fee Related
- 1986-01-07 JP JP61001957A patent/JPS61161267A/ja active Pending
- 1986-01-07 EP EP86300056A patent/EP0190817B1/de not_active Expired - Lifetime
-
1989
- 1989-07-05 AU AU37887/89A patent/AU3788789A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| GR860018B (en) | 1986-04-29 |
| AU588562B2 (en) | 1989-09-21 |
| DK2886D0 (da) | 1986-01-03 |
| EP0190817A1 (de) | 1986-08-13 |
| ES550699A0 (es) | 1987-03-01 |
| DK2886A (da) | 1986-07-09 |
| EP0190817B1 (de) | 1990-09-05 |
| AU3788789A (en) | 1989-10-19 |
| DE3673835D1 (de) | 1990-10-11 |
| PT81786B (pt) | 1988-05-27 |
| JPS61161267A (ja) | 1986-07-21 |
| PT81786A (en) | 1986-02-01 |
| ES8703844A1 (es) | 1987-03-01 |
| CA1269668A (en) | 1990-05-29 |
| AU5180186A (en) | 1986-07-17 |
| ZA8665B (en) | 1986-08-27 |
| US4728741A (en) | 1988-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE45731T1 (de) | 3-substituierte 2-oxindole-1-carboxamide, als analgetische und antiinflammatorische mittel verwendet. | |
| KR870700620A (ko) | 신규 약리학적 화합물 | |
| SE9402558D0 (sv) | Ny användning av azatricykloderivat och farmaceutiska kompositioner innehållande desamma | |
| ES8801785A1 (es) | Un procedimiento para la preparacion de nuevas azetidinonas sustituidas. | |
| ATE56207T1 (de) | Dopamin-beta-hydroxylase-inhibitoren. | |
| LV10954A (lv) | Benzimidazola atvasinajumi to iegusanas panemiens un tos saturosa farmaceitiska kompozicija | |
| DK0598770T3 (da) | Pyrazinderivater samt fremstilling og anvendelse deraf | |
| FI902673A7 (fi) | Anti-inflammatoorisia ja analgeettisia yhdisteitä, niitä sisältäviä se oksia ja menetelmiä niiden valmistamiseksi sekä niiden käyttö | |
| FR2415630A1 (fr) | Nouvelles 5-vinyl-2-pyrrolidones, utiles notamment dans la preparation des acides 4-amino-5-hexenoique et 4-amino-5-hexynoique, et leur preparation | |
| DK164164C (da) | 2,4-diphenyl-1,3-dioxanderivater og fremgangsmaade til fremstilling deraf samt farmaceutisk middel indeholdende derivaterne og disses anvendelse til fremstilling af det farmaceutiske middel | |
| FR2395998A1 (fr) | Nouveaux derives de la thiazolidine et leur application dans le traitement de l'hypertension | |
| ES8706651A1 (es) | Un procedimiento para preparar derivados de tetrazol. | |
| DK601583D0 (da) | Carbamyloxybenzhydrolderivater | |
| NO166125C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive aroyl-substituerte dihydro-1,4-tiaziner. | |
| ATE56440T1 (de) | 6-oxo-pyridazinyl-verbindungen. | |
| IT1224404B (it) | Composti attivi sul sistema cardiovascolare | |
| IT1190662B (it) | Composto ad attivita' analgesica,antiinfiammatoria e mucoregolatrice procedimento per la sua prepatazione e relative composizioni farmaceutiche | |
| ATE51227T1 (de) | Chinatsalze der antimalarischen verbindung mefloquin. | |
| DE69002027D1 (de) | (3-diethylaminopropyl)-1-amino-5-methyldipyrido(4,3-b)(3,4-f)indoltrihydrochlorid. | |
| TH2892A (th) | อนุพันธ์ต่างๆ ของออกซิซาลิซิลอะมิโด |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |